{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:59:21Z","timestamp":1792609161545,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI176470"],"award-info":[{"award-number":["U01AI176470"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA281868"],"award-info":[{"award-number":["U01CA281868"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01AI140761"],"award-info":[{"award-number":["R01AI140761"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA253188"],"award-info":[{"award-number":["R35CA253188"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA021765"],"award-info":[{"award-number":["P30CA021765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["1T32CA272387"],"award-info":[{"award-number":["1T32CA272387"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xcrm.2026.103008","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:10:23Z","timestamp":1787670623000},"page":"103008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting Regnase-1 in B7-H3-CAR T cells reprograms the tumor microenvironment and enhances antitumor efficacy for osteosarcoma"],"prefix":"10.1016","volume":"7","author":[{"given":"Adeleye O.","family":"Adeshakin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Scott","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"M\u00e9tais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"KC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Peche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie S.","family":"Prater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna M.","family":"Langfitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeoungeun J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Chabot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azusa","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GaHyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengdar Q.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shondra M.","family":"Pruett-Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay J.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason T.","family":"Yustein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giedre","family":"Krenciute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"DeRenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-7468","authenticated-orcid":false,"given":"Stephen","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103008_bib1","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2024.19462","article-title":"CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review","volume":"332","author":"Brudno","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.xcrm.2026.103008_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41587-024-02446-2","article-title":"Beyond the blood: expanding CAR T cell therapy to solid tumors","volume":"43","author":"Uslu","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103008_bib3","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.ymthe.2020.09.015","article-title":"CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?","volume":"28","author":"Wagner","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.103008_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","article-title":"CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn","volume":"21","author":"Albelda","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103008_bib5","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJMoa2210859","article-title":"GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma","volume":"388","author":"Del Bufalo","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103008_bib6","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41586-024-08261-8","article-title":"Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers","volume":"637","author":"Steffin","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103008_bib7","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s43018-024-00749-6","article-title":"Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial","volume":"5","author":"Hegde","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.103008_bib8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1158\/2159-8290.CD-24-0102","article-title":"CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma","volume":"14","author":"Pal","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103008_bib9","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1038\/s41591-023-02612-0","article-title":"CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial","volume":"29","author":"Mackensen","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103008_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41586-019-1821-z","article-title":"Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy","volume":"576","author":"Wei","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103008_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1182\/blood.2020009309","article-title":"Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL","volume":"138","author":"Zheng","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103008_bib12","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1158\/2159-8290.CD-20-1144","article-title":"CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells","volume":"11","author":"Kumar","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103008_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh0272","article-title":"Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity","volume":"13","author":"Prinzing","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103008_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41586-022-05126-w","article-title":"RASA2 ablation in T cells boosts antigen sensitivity and long-term function","volume":"609","author":"Carnevale","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103008_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103941","article-title":"Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion","volume":"77","author":"Gumber","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2026.103008_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.xcrm.2026.103008_bib17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-05707-3","article-title":"CAR immune cells: design principles, resistance and the next generation","volume":"614","author":"Labanieh","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103008_bib18","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1158\/2159-8290.CD-20-0896","article-title":"A Chimeric GM-CSF\/IL18 Receptor to Sustain CAR T-cell Function","volume":"11","author":"Lange","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103008_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009743","article-title":"IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors","volume":"12","author":"Wickman","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.103008_bib20","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41551-023-01143-w","article-title":"Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK\/STAT signalling","volume":"8","author":"Bell","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2026.103008_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1101\/sqb.2013.78.019877","article-title":"Regnase-1, a ribonuclease involved in the regulation of immune responses","volume":"78","author":"Akira","year":"2013","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.xcrm.2026.103008_bib22","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200971","article-title":"Regnase-1 is essential for B cell homeostasis to prevent immunopathology","volume":"218","author":"Bhat","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2026.103008_bib23","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.immuni.2024.05.006","article-title":"Deletion of the mRNA endonuclease Regnase-1 promotes NK cell anti-tumor activity via OCT2-dependent transcription of Ifng","volume":"57","author":"Sun","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103008_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2218632120","article-title":"Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells","volume":"120","author":"Mai","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103008_bib25","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232368","article-title":"Induction of immortal-like and functional CAR T cells by defined factors","volume":"221","author":"Wang","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2026.103008_bib26","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1016\/j.cell.2021.08.004","article-title":"The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function","volume":"184","author":"Johnson","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103008_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.omto.2020.06.018","article-title":"Route of 41BB\/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28\u03b6 T Cells","volume":"18","author":"Nguyen","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.xcrm.2026.103008_bib28","first-page":"4048","article-title":"Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors","volume":"61","author":"Modak","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103008_bib29","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-18-0432","article-title":"CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors","volume":"25","author":"Majzner","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103008_bib30","article-title":"CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives","volume":"3","author":"Epperly","year":"2024","journal-title":"EJC Paediatr. Oncol."},{"key":"10.1016\/j.xcrm.2026.103008_bib31","article-title":"New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3","volume":"12","author":"Koumprentziotis","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.xcrm.2026.103008_bib32","first-page":"3093","article-title":"Expression of different chemokines by human osteosarcoma cells in response to tumor necrosis factor-alpha","volume":"19","author":"Grigolo","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.xcrm.2026.103008_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","article-title":"Osteosarcoma","volume":"8","author":"Beird","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2026.103008_bib34","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1200\/JCO.22.02767","article-title":"Prognostic Factors in High-Grade Osteosarcoma of theExtremities or Trunk: An Analysis of 1,702 Patients Treatedon Neoadjuvant Cooperative Osteosarcoma Study GroupProtocols","volume":"41","author":"Bielack","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103008_bib35","doi-asserted-by":"crossref","first-page":"18219","DOI":"10.1002\/cam4.6409","article-title":"Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group","volume":"12","author":"Mettmann","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.xcrm.2026.103008_bib36","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41590-021-00964-8","article-title":"BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells","volume":"22","author":"Seo","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.103008_bib37","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41590-021-00965-7","article-title":"BATF regulates progenitor to cytolytic effector CD8(+) T cell transition during chronic viral infection","volume":"22","author":"Chen","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.103008_bib38","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41587-023-02060-8","article-title":"IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases","volume":"42","author":"Zhao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103008_bib39","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1016\/j.cell.2021.07.015","article-title":"CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment","volume":"184","author":"Di Pilato","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103008_bib40","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1073\/pnas.1101881108","article-title":"Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103008_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2021.12.012","article-title":"Metabolic adaptation of lymphocytes in immunity and disease","volume":"55","author":"Chapman","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103008_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103008_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq3016","article-title":"Metabolic challenges and interventions in CAR T cell therapy","volume":"8","author":"Peng","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2026.103008_bib44","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41586-025-08732-6","article-title":"VDAC2 loss elicits tumour destruction and inflammation for cancer therapy","volume":"640","author":"Yuan","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103008_bib45","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.cell.2016.08.052","article-title":"A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells","volume":"166","author":"Singer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103008_bib46","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103008_bib47","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103008_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay6017","article-title":"Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics","volume":"5","author":"Alshetaiwi","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2026.103008_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.691741","article-title":"A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells","volume":"12","author":"Talbot","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103008_bib50","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1158\/1078-0432.CCR-22-0822","article-title":"Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19","volume":"28","author":"Diorio","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103008_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001511","article-title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events","volume":"8","author":"Maus","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.103008_bib52","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s44321-024-00055-9","article-title":"Early induction of cytokine release syndrome by rapidly generated CAR T cells in preclinical models","volume":"16","author":"Jamali","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2026.103008_bib53","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-21-0470","article-title":"Cytokine Release Syndrome By T-cell-Redirecting Therapies: Can We Predict and Modulate Patient Risk?","volume":"27","author":"Van De Vyver","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103008_bib54","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221988","article-title":"Self-regulating CAR-T cells modulate cytokine release syndrome in adoptive T-cell therapy","volume":"221","author":"Lin","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2026.103008_bib55","article-title":"Pan-cancer mapping of single CD8(+) T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity","volume":"5","author":"Tooley","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.103008_bib56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.celrep.2018.06.054","article-title":"Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells","volume":"24","author":"Zhao","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103008_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001772","article-title":"Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes","volume":"9","author":"Ligon","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.103008_bib58","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.ymthe.2017.05.012","article-title":"CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma","volume":"25","author":"Heczey","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.103008_bib59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00262-024-03837-9","article-title":"PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis","volume":"73","author":"Blobner","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.xcrm.2026.103008_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164947","article-title":"MYC regulates CSF1 expression via microRNA 17\/20a to modulate tumor-associated macrophages in osteosarcoma","volume":"8","author":"Nirala","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.103008_bib61","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41598-023-50703-2","article-title":"Whole-exome sequencing reveals Lewis lung carcinoma is a hypermutated Kras\/Nras-mutant cancer with extensive regional mutation clusters in its genome","volume":"14","author":"He","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103008_bib62","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.immuni.2018.03.004","article-title":"Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape","volume":"48","author":"Wellenstein","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103008_bib63","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201908224","article-title":"Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling","volume":"219","author":"Nguyen","year":"2020","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.103008_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1303935","article-title":"Lymphodepletion - an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle","volume":"14","author":"Lickefett","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103008_bib65","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.ymthe.2021.02.024","article-title":"Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity","volume":"29","author":"Murad","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.103008_bib66","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41467-020-20599-x","article-title":"Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma","volume":"12","author":"Agliardi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103008_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008566","article-title":"Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity","volume":"12","author":"Shabaneh","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.103008_bib68","doi-asserted-by":"crossref","first-page":"7196","DOI":"10.1038\/s41467-025-61427-4","article-title":"Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function","volume":"16","author":"Barisa","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103008_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-71354-7","article-title":"Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination","volume":"17","author":"Warmuth","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103008_bib70","article-title":"Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells","volume":"34","author":"Jeong","year":"2026","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.xcrm.2026.103008_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-40628-x","article-title":"Low-affinity binding of anti-B7-H3 clone MJ18 to murine B7-H3 fails to induce tumor regression","volume":"16","author":"Guly\u00e1s","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103008_bib72","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/neuonc\/noaa278","article-title":"Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery","volume":"23","author":"Haydar","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2026.103008_bib73","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/2159-8290.CD-22-0750","article-title":"Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety","volume":"13","author":"Vitanza","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103008_bib74","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41591-024-03451-3","article-title":"Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial","volume":"31","author":"Vitanza","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103008_bib75","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1200\/JCO.23.02229","article-title":"STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed\/Refractory Solid Tumors","volume":"42","author":"Pinto","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103008_bib76","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1158\/2767-9764.CRC-23-0538","article-title":"B7-H3-Targeting Chimeric Antigen Receptors Epstein-Barr Virus-specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3-positive Solid Tumors","volume":"4","author":"Yeo","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.xcrm.2026.103008_bib77","article-title":"Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapy","volume":"7","author":"Bajgain","year":"2026","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.103008_bib78","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1038\/onc.2014.429","article-title":"NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma","volume":"34","author":"Zhao","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.103008_bib79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00001813-200202000-00007","article-title":"Eradication of osteosarcoma lung metastasis using intranasal gemcitabine","volume":"13","author":"Jia","year":"2002","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.xcrm.2026.103008_bib80","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/mt.2009.133","article-title":"Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression","volume":"17","author":"Ahmed","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.103008_bib81","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103008_bib82","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103008_bib83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12688\/f1000research.22139.1","article-title":"scRepertoire: An R-based toolkit for single-cell immune receptor analysis","volume":"9","author":"Borcherding","year":"2020","journal-title":"F1000Res."},{"key":"10.1016\/j.xcrm.2026.103008_bib84","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics","volume":"20","author":"Jin","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2026.103008_bib85","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103008_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103008_bib87","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.103008_bib88","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","article-title":"CRISPR-Cas9 knockin mice for genome editing and cancer modeling","volume":"159","author":"Platt","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103008_bib89","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-0716-2990-1_6","article-title":"High-Throughput Analysis of CRISPR-Cas9 Editing Outcomes in Cell and Animal Models Using CRIS.py","volume":"2631","author":"Narina","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2026.103008_bib90","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1038\/s41598-019-40896-w","article-title":"CRIS.py: A Versatile and High-throughput Analysis Program for CRISPR-based Genome Editing","volume":"9","author":"Connelly","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103008_bib91","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2010-01-265041","article-title":"Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103008_bib92","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccell.2017.03.005","article-title":"Eradication of Tumors through Simultaneous Ablation of CD276\/B7-H3-Positive Tumor Cells and Tumor Vasculature","volume":"31","author":"Seaman","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103008_bib93","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1182\/bloodadvances.2021006293","article-title":"Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL","volume":"6","author":"Talleur","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2026.103008_bib94","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1158\/1078-0432.CCR-12-0715","article-title":"Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity","volume":"18","author":"Loo","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103008_bib95","article-title":"Population-scale cellular GUIDE-seq-2 and biochemical CHANGE-seq-R profiles reveal human genetic variation frequently affects Cas9 off-target activity","author":"Lazzarotto","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.103008_bib96","article-title":"Peptide-scFv antigen recognition domains effectively confer CAR T cell multiantigen specificity","volume":"5","author":"Zoine","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.103008_bib97","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103008_bib98","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","article-title":"SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity","volume":"620","author":"Guo","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103008_bib99","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.immuni.2018.11.014","article-title":"Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1(-)CD8(+) Tumor-Infiltrating T Cells","volume":"50","author":"Kurtulus","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103008_bib100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","article-title":"TIM-3 restrains anti-tumour immunity by regulating inflammasome activation","volume":"595","author":"Dixon","year":"2021","journal-title":"Nature"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:15:37Z","timestamp":1789503337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":100,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666379126004258"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103008","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Regnase-1 in B7-H3-CAR T cells reprograms the tumor microenvironment and enhances antitumor efficacy for osteosarcoma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103008"}}